MedKoo Cat#: 562314 | Name: Piroheptine HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Piroheptine HCl is an anticholinergic agent. It acts by inhibiting dopamine uptake and completely preventing loss of striatal dopamine in MPTP-treated mice.

Chemical Structure

Piroheptine HCl
Piroheptine HCl
CAS#16378-22-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 562314

Name: Piroheptine HCl

CAS#: 16378-22-6 (HCl)

Chemical Formula: C22H26ClN

Exact Mass:

Molecular Weight: 339.90

Elemental Analysis: C, 77.74; H, 7.71; Cl, 10.43; N, 4.12

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
16378-21-5 (free base); 16378-22-6 (HCl)
Synonym
Piroheptine HCl; Piroheptine Hydrochloride; Trimol;
IUPAC/Chemical Name
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-1-ethyl-2-methylpyrrolidine hydrochloride
InChi Key
PLJNHZOEOXGWIR-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H25N.ClH/c1-3-23-15-14-19(16(23)2)22-20-10-6-4-8-17(20)12-13-18-9-5-7-11-21(18)22;/h4-11,16H,3,12-15H2,1-2H3;1H
SMILES Code
CCN1C(C)/C(CC1)=C2C(C=CC=C3)=C3CCC4=C\2C=CC=C4.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 339.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Katayama S, Ishizaki F, Yamamura Y, Khoriyama T, Kito S. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain. Res Commun Chem Pathol Pharmacol. 1990 Sep;69(3):261-70. PubMed PMID: 2236897. 2: Otani K, Hirano T, Kondo T, Kaneko S, Fukushima Y, Noda K, Tashiro Y. Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug. Br J Psychiatry. 1990 Jul;157:128-30. PubMed PMID: 1975759. 3: Saitoh T. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl. J Neurol Sci. 1988 Feb;83(2-3):161-6. PubMed PMID: 3258627. 4: Ohashi T, Akita H, Tamura T, Noda K, Honda F. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain. Arzneimittelforschung. 1972 Jun;22(6):966-72. PubMed PMID: 5068358. 5: Hitomi M, Kumadaki N, Furukawa T, Ito N, Sato Y, Kumada S. Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidin e. I. Effects on drug-induced tremor and catatonia, and on adrenergic actions. Arzneimittelforschung. 1972 Jun;22(6):953-61. PubMed PMID: 4626187. 6: Hitomi M, Watanabe N, Kumadaki N, Kumada S. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity. Arzneimittelforschung. 1972 Jun;22(6):961-6. PubMed PMID: 4403219.